HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cheng Jiang Selected Research

Selenious Acid (Selenite)

3/2009In vivo molecular mediators of cancer growth suppression and apoptosis by selenium in mammary and prostate models: lack of involvement of gadd genes.
5/2007Differential involvement of reactive oxygen species in apoptosis induced by two classes of selenium compounds in human prostate cancer cells.
7/2004Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells.
10/2002Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cheng Jiang Research Topics

Disease

69Neoplasms (Cancer)
05/2024 - 07/2002
30Prostatic Neoplasms (Prostate Cancer)
02/2024 - 07/2002
15Inflammation (Inflammations)
01/2022 - 12/2012
8Neoplasm Metastasis (Metastasis)
01/2023 - 12/2006
8Breast Neoplasms (Breast Cancer)
01/2023 - 09/2003
8Alzheimer Disease (Alzheimer's Disease)
01/2021 - 06/2013
7Infections
01/2023 - 12/2012
7Carcinogenesis
01/2023 - 09/2006
5Glioma (Gliomas)
05/2024 - 01/2023
5Parkinson Disease (Parkinson's Disease)
12/2023 - 01/2020
5Obesity
01/2021 - 05/2015
5Body Weight (Weight, Body)
11/2018 - 03/2009
4Colorectal Neoplasms (Colorectal Cancer)
03/2023 - 01/2018
4Pain (Aches)
01/2023 - 12/2012
4COVID-19
01/2023 - 12/2020
4Adenocarcinoma
01/2021 - 09/2015
4Diabetes Mellitus
01/2019 - 06/2013
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 01/2016
3Chronic Disease (Chronic Diseases)
12/2023 - 09/2021
3Pulmonary Fibrosis (Fibrosing Alveolitis)
11/2023 - 11/2017
3Stroke (Strokes)
09/2023 - 12/2018
3Necrosis
01/2023 - 01/2019
3Acute Lung Injury
01/2022 - 02/2019
3Brain Ischemia (Cerebral Ischemia)
01/2022 - 01/2018
3Neuroendocrine Carcinoma
01/2022 - 12/2016
3Traumatic Brain Injuries (Traumatic Brain Injury)
10/2020 - 01/2018
3Disease Progression
01/2020 - 12/2018
3Fatigue
01/2017 - 01/2015
3Leukemia
12/2012 - 07/2002
2Fibrosis (Cirrhosis)
01/2024 - 10/2019
2Movement Disorders (Movement Disorder)
12/2023 - 11/2021
2Dementia (Dementias)
12/2023 - 01/2017
2Bacterial Infections (Bacterial Infection)
10/2023 - 01/2021
2Melanoma (Melanoma, Malignant)
03/2023 - 01/2018
2Pancreatic Neoplasms (Pancreatic Cancer)
03/2023 - 01/2023
2Infarction (Infarctions)
01/2023 - 01/2022
2Gouty Arthritis
01/2023 - 04/2021
2Reperfusion Injury
01/2023 - 01/2022
2Ischemic Stroke
01/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
05/2024 - 03/2009
15SeleniumIBA
01/2023 - 10/2002
14Androgen Receptors (Androgen Receptor)IBA
01/2023 - 01/2006
9Biomarkers (Surrogate Marker)IBA
01/2024 - 05/2004
9methaneselenolIBA
01/2016 - 07/2002
8CaspasesIBA
03/2023 - 07/2002
8decursinIBA
01/2021 - 01/2006
7Messenger RNA (mRNA)IBA
05/2023 - 03/2009
7AndrogensIBA
01/2020 - 05/2004
7methylselenic acidIBA
01/2016 - 10/2002
6Peptides (Polypeptides)IBA
11/2023 - 08/2014
6Ethanol (Ethyl Alcohol)IBA
01/2021 - 01/2006
5SynucleinsIBA
12/2023 - 01/2020
5Indicators and Reagents (Reagents)IBA
09/2023 - 05/2004
5Selenium CompoundsIBA
05/2010 - 07/2002
4RNA (Ribonucleic Acid)IBA
01/2024 - 01/2023
4Neuroprotective AgentsIBA
01/2023 - 01/2017
4Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 07/2017
4TensinsIBA
01/2022 - 08/2005
4CytokinesIBA
01/2022 - 01/2017
4DNA (Deoxyribonucleic Acid)IBA
10/2017 - 07/2004
4Amyloid (Amyloid Fibrils)IBA
01/2015 - 06/2013
4LigandsIBA
04/2011 - 07/2006
4Selenious Acid (Selenite)IBA
03/2009 - 10/2002
3Chloroquine (Aralen)FDA LinkGeneric
02/2024 - 05/2016
3HexokinaseIBA
02/2024 - 05/2016
3Deoxyglucose (2 Deoxy D glucose)IBA
02/2024 - 05/2016
3Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2024 - 08/2005
3LuciferasesIBA
05/2023 - 01/2019
3Caspase 3 (Caspase-3)IBA
01/2023 - 11/2021
3Histones (Histone)IBA
01/2023 - 04/2011
3Phosphotransferases (Kinase)IBA
01/2023 - 03/2009
3Complement System Proteins (Complement)IBA
01/2022 - 10/2015
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2022 - 01/2016
3CateninsIBA
01/2022 - 01/2018
3LipopolysaccharidesIBA
01/2022 - 02/2019
3PyranocoumarinsIBA
01/2021 - 09/2015
3Streptozocin (Streptozotocin)FDA Link
10/2019 - 01/2015
3Glucose (Dextrose)FDA LinkGeneric
10/2019 - 05/2015
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018 - 11/2005
3Insulin (Novolin)FDA Link
11/2015 - 12/2004
3Estrogens (Estrogen)FDA Link
01/2007 - 06/2002
2NLR ProteinsIBA
01/2024 - 12/2023
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2024 - 07/2006
2Bleomycin (Blenoxane)FDA LinkGeneric
11/2023 - 01/2023
2PolymersIBA
10/2023 - 01/2023
2cannabidiol hydroxyquinone (HU331)IBA
03/2023 - 03/2023
2CannabinoidsIBA
03/2023 - 03/2023
2Pemetrexed (MTA)FDA Link
01/2023 - 01/2022
2AntibodiesIBA
01/2023 - 01/2023
2NucleotidesIBA
01/2023 - 04/2021
2ChromatinIBA
01/2023 - 01/2020
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2023 - 07/2004
2NAD (NADH)IBA
01/2023 - 01/2020

Therapy/Procedure

23Therapeutics
05/2024 - 09/2008
14Chemoprevention
01/2020 - 10/2002
10Drug Therapy (Chemotherapy)
05/2024 - 07/2004
6Chinese Traditional Medicine (Traditional Chinese Medicine)
04/2022 - 04/2011
3Intraperitoneal Injections
02/2024 - 11/2018
3Cardiopulmonary Resuscitation (CPR)
04/2015 - 12/2010
2Immunotherapy
05/2024 - 08/2023